CYTOKINETICS INC — Director's Dealing 2021

Apr 9, 2021

SEC Form 4/A — Form 4/A

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2020-05-19

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-19	Common Stock	M	3333	$16.86	Acquired	9583	Direct
2020-05-19	Common Stock	F	2684	$20.93	Disposed	6899	Direct

Footnotes

F1: This Form 4/A is being filed to report the correct amount of securities beneficially owned following reported transaction(s) on 5/19/2020. The original Form 4 filed on May 20, 2020 by the Reporting Person did not include the 6,000 shares that Reporting Person acquired on November 19, 2019, as reported on Reporting Persons Form 4 filed on 1/02/2020.

F2: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 649 shares of Common Stock on the net exercise of a stock option to purchase 3,333 shares of Common Stock. The Issuer withheld 2,684 shares of Common Stock underlying the stock option for payment of the exercise price using a stock price on May 19, 2020 of $20.93. In addition to the withholding of 2,684 shares of Common Stock, the Reporting Person has paid $18.26 in cash to the Issuer for the remainder of his exercise price liability.